Mapping FACT-P and EORTC QLQ-C30 to Patient Health Status Measured by EQ-5D in Metastatic Hormone-Refractory Prostate Cancer Patients

Value in Health ◽

10.1111/j.1524-4733.2007.00195.x ◽

2007 ◽

Vol 10 (5) ◽

pp. 408-414 ◽

Author(s):

Eric Q. Wu ◽

Parvez Mulani ◽

Max H. Farrell ◽

Darryl Sleep

Keyword(s):

Prostate Cancer ◽

Health Status ◽

Cancer Patients ◽

Hormone Refractory Prostate Cancer ◽

Patient Health Status ◽

Patient Health ◽

Eortc Qlq C30 ◽

Hormone Refractory ◽

Download Full-text

Baseline quality of life measured with the EORTC QLQ-C30 helps to select a subset of ‘good prognosis’ metastatic hormone refractory prostate cancer patients

European Journal of Cancer ◽

10.1016/s0959-8049(01)81290-9 ◽

2001 ◽

Vol 37 ◽

pp. S218 ◽

Author(s):

L. Collette ◽

S.D. Fossa ◽

G.O.N. Oosterhof ◽

W. Albrecht ◽

G. van Andel ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Cancer Patients ◽

Good Prognosis ◽

Hormone Refractory Prostate Cancer ◽

Eortc Qlq C30 ◽

Hormone Refractory ◽

Download Full-text

PCN33 MAPPING FACT-PAND EORTC QLQ-C30TOTHE EQ-5D HEALTH UTILITY IN METASTATIC HORMONE-REFRACTORY PROSTATE CANCER PATIENTS

Value in Health ◽

10.1016/s1098-3015(10)64657-8 ◽

2006 ◽

Vol 9 (3) ◽

pp. A114

Author(s):

E Wu ◽

P Mulani ◽

MH Farrell ◽

D Sleep

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Health Utility ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Download Full-text

MA2 Mapping Fact-P to Country Specific Patient Health Status Measured by EQ-5D in Metastatic Castrate Resistant Prostate Cancer Patients

Value in Health ◽

10.1016/j.jval.2011.08.060 ◽

2011 ◽

Vol 14 (7) ◽

pp. A242 ◽

Author(s):

M. Spencer ◽

J. Diels

Keyword(s):

Prostate Cancer ◽

Health Status ◽

Cancer Patients ◽

Specific Patient ◽

Patient Health Status ◽

Patient Health ◽

Castrate Resistant Prostate Cancer ◽

Castrate Resistant ◽

Country Specific

Download Full-text

Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients

Prostate Cancer and Prostatic Diseases ◽

10.1038/sj.pcan.4500752 ◽

2004 ◽

Vol 7 (4) ◽

pp. 350-354 ◽

Author(s):

P Rodrigues ◽

F Hering ◽

J C Campagnari

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases

Journal of Managed Care Pharmacy ◽

10.18553/jmcp.2012.18.1.74 ◽

2012 ◽

Vol 18 (1) ◽

pp. 74-75

Author(s):

Michael Rader ◽

Carsten Goessl ◽

Ze Cong

Keyword(s):

Prostate Cancer ◽

Economic Evaluation ◽

Zoledronic Acid ◽

Bone Metastases ◽

Cancer Patients ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

535 Validation of EORTC QLQ-C30 and QLQ-PR25 questionnaires for quality of life assessment among Polish prostate cancer patients

European Urology Supplements ◽

10.1016/s1569-9056(14)60527-3 ◽

2014 ◽

Vol 13 (1) ◽

pp. e535

Author(s):

M. Sosnowski ◽

Z. Wolski ◽

Z. Jablonowski

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Cancer Patients ◽

Life Assessment ◽

Quality Of Life Assessment ◽

Eortc Qlq C30 ◽

Download Full-text

The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid

Cancer ◽

10.1002/cncr.22504 ◽

2007 ◽

Vol 109 (6) ◽

pp. 1090-1096 ◽

Author(s):

William K. Oh ◽

Kevin Proctor ◽

Mari Nakabayashi ◽

Carolyn Evan ◽

Lauren K. Tormey ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Renal Impairment ◽

Bone Metastases ◽

Cancer Patients ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

EVALUATION OF OUTCOMES AND GENETIC PREDICTIVE FACTORS FOR PROGNOSIS AND TOXICITY IN HORMONE-REFRACTORY PROSTATE CANCER PATIENTS FOLLOWING COMBINATION THERAPY WITH DOCETAXEL, ESTRAMUSTINE, AND CARBOPLATIN

The Journal of Urology ◽

10.1016/s0022-5347(09)60834-x ◽

2009 ◽

Vol 181 (4S) ◽

pp. 293-293

Author(s):

Shintaro Narita ◽

Hiroshi Tsuruta ◽

Mitsuru Saito ◽

Teruaki Kumazawa ◽

Yohei Horikawa ◽

...

Keyword(s):

Prostate Cancer ◽

Combination Therapy ◽

Cancer Patients ◽

Predictive Factors ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Prospective Study of Estramustine Phosphate for Hormone Refractory Prostate Cancer Patients following Androgen Deprivation Therapy

Urologia Internationalis ◽

10.1159/000085926 ◽

2005 ◽

Vol 75 (1) ◽

pp. 43-49 ◽

Author(s):

Daisaku Hirano ◽

Sadatsugu Minei ◽

Yuichi Kishimoto ◽

Kenya Yamaguchi ◽

Takahiko Hachiya ◽

...

Keyword(s):

Prostate Cancer ◽

Prospective Study ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

Hormone Refractory Prostate Cancer ◽

Estramustine Phosphate ◽

Hormone Refractory

Download Full-text

Bone alkaline phosphatase doubling time and outcome in metastatic hormone-refractory prostate cancer patients

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4621 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4621-4621

Author(s):

D. J. Sleep ◽

S. M. Hulting ◽

J. D. Isaacson ◽

A. R. Allen

Keyword(s):

Prostate Cancer ◽

Alkaline Phosphatase ◽

Cancer Patients ◽

Doubling Time ◽

Bone Alkaline Phosphatase ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text